Canaccord Genuity Starts Novadaq Technologies (NVDQ) at Buy
Tweet Send to a FriendGet Alerts NVDQ Hot Sheet
Price: $13.98 +0.58%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 17 | New: 24
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 24 | Down: 17 | New: 24
Trade NVDQ Now!
Canaccord Genuity initiates coverage on Novadaq Technologies (NASDAQ: NVDQ) with a Buy. PT $15.00.
The analyst comments, "Novadaq possesses a unique technology that we believe could become a standard-of-care intra-operative imaging modality across multiple open and minimally-invasive surgical applications. We think the most appropriate relative comparisons to use to value NVDQ are other high-growth med-tech companies whose technologies possess similar attributes – i.e., established or emerging standard of care, addresses nascent growth markets, and is improving outcomes for patients. What’s more, we think NVDQ will supply more proof that its technology provides cost savings for the hospital, which is becoming increasingly important in today’s healthcare environment."
For an analyst ratings summary and ratings history on Novadaq Technologies click here. For more ratings news on Novadaq Technologies click here.
Shares of Novadaq Technologies closed at $11.46 yesterday, with a 52 week range of $5.27-$12.20.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The analyst comments, "Novadaq possesses a unique technology that we believe could become a standard-of-care intra-operative imaging modality across multiple open and minimally-invasive surgical applications. We think the most appropriate relative comparisons to use to value NVDQ are other high-growth med-tech companies whose technologies possess similar attributes – i.e., established or emerging standard of care, addresses nascent growth markets, and is improving outcomes for patients. What’s more, we think NVDQ will supply more proof that its technology provides cost savings for the hospital, which is becoming increasingly important in today’s healthcare environment."
For an analyst ratings summary and ratings history on Novadaq Technologies click here. For more ratings news on Novadaq Technologies click here.
Shares of Novadaq Technologies closed at $11.46 yesterday, with a 52 week range of $5.27-$12.20.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Global Equities Starts Tesla Motors (TSLA) at Overweight
- Cowen Starts Teradata (TDC) at Underperform
- Goldman Sachs Resumes / Downgrades Seadrill Ltd. (SDRL) to Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
